Research shows the frequency of Alzheimer's disease in women as compared to men, leading researchers to study the role of estrogen and hormone therapy in cognitive decline during menopause; however, research cannot confirm whether perimenopausal women can benefit from hormone therapy. The various cognitive phenomena and markers of small vessel brain disease during menopause are also unclear as to how they interact with each other.